NEW YORK (GenomeWeb News) — Panagene has licensed PNA monomers from the Copenhagen Inventor Group that allows Panagene to synthesize, make, and sell peptide nucleic acids, the company said Tuesday.
 
The South Korean company adds this license agreement to a previous one with CIG for patents for PNA custom synthesis.
 
Panagene estimated that it is currently around 5 percent of the DNA/RNA synthesis market and said the new license will enable it to increase this share “significantly.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.